Mercodia > Products > Human > Product

Mercodia MPO ELISA

Catalog nr 10-1176-01

Description
Immunoassay for quantitative determination of human MPO (myeloperoxidase) in serum or plasma.

Advantages
Calibrated against a highly purified, fully validated, commercially available MPO preparation.

Notes
If controls are needed please contact Mercodia for further information


Format 1 x 96 wells
Sample Serum, plasma
Sample volume 25 μL    
Assay range 3,5 - 200 μg/L    
Sensitivity ≤ 3 μg/L    
Incubation (min) 60+60+15

 

References
  • van der Zwan, L, P, Scheffer, P (2011)
    Systemic inflammation is linked to low arginine and high ADMA plasma levels resulting in an unfavorable NOS substrate-to-inhibitor ratio - the Hoorn Study
    Read abstract
  • Metzig, A, M, Schwarzenberg, S (2011)
    Postprandial Endothelial Function, Inflammation, and Oxidative Stress in Obese Children and Adolescents
    Read abstract
  • Lerman, R, H, Desai, A (2014)
    A Phytochemical-rich Multivitamin-multimineral Supplement Is Bioavailable and Reduces Serum Oxidized Low-density Lipoprotein, Myeloperoxidase, and Plasminogen Activator Inhibitor-1 in a Four-week Pilot trial of Healthy Individuals
    Read abstract
More references
Search

Ask Mercodia for Quotation


Direction for Use (PDF)


Technotes

2-TN34-0106 Instruction handwash2.pdf 2-TN34-0107 Instruction for test of microplate reader2.pdf Tech note MPO Performance.pdf 2-TN34-0108 Troubleshooting2.pdf 2-TN34-0120 Stability of components from opened Mercodia ELISA kit2.pdf

Posters

Poster Risk Marker for Atherosclerosis.pdf Poster MPO as a Biomarker.pdf

Product sheets

10-1176-01 MPO.pdf

MSDS

MPO ELISA MSDS Rev 121126.pdf


Movies



View large movie Enzyme immunoassay for quantification of insulin